Impact of Treating Oral Disease on Preventing Vascular Diseases: A Model-Based Cost-effectiveness Analysis of Periodontal Treatment Among Patients With Type 2 Diabetes
Authors:
- 1 March 2020
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 43 (3) , 563-571
Abstract
OBJECTIVE: Previous randomized trials found that treating periodontitis improved glycemic control in patients with type 2 diabetes (T2D), thus lowering the risks of developing T2D-related microvascular diseases and cardiovascular disease (CVD). Some payers in the U.S. have started covering nonsurgical periodontal treatment for those with chronic conditions, such as diabetes. We sought to identify the cost-effectiveness of expanding periodontal treatment coverage among patients with T2D. RESEARCH DESIGN AND METHODS: A cost-effectiveness analysis was conducted to estimate lifetime costs and health gains using a stochastic microsimulation model of oral health conditions, T2D, T2D-related microvascular diseases, and CVD of the U.S. population. Model parameters were obtained from the nationally representative National Health and Nutrition Examination Survey (NHANES) (2009–2014) and randomized trials of periodontal treatment among patients with T2D. RESULTS: Expanding periodontal treatment coverage among patients with T2D and periodontitis would be expected to avert tooth loss by 34.1% (95% CI −39.9, −26.5) and microvascular diseases by 20.5% (95% CI −31.2, −9.1), 17.7% (95% CI −32.7, −4.7), and 18.4% (95% CI −34.5, −3.5) for nephropathy, neuropathy, and retinopathy, respectively. Providing periodontal treatment to the target population would be cost saving from a health care perspective at a total net savings of $5,904 (95% CI −6,039, −5,769) with an estimated gain of 0.6 quality-adjusted life years per capita (95% CI 0.5, 0.6). CONCLUSIONS: Providing nonsurgical periodontal treatment to patients with T2D and periodontitis would be expected to significantly reduce tooth loss and T2D-related microvascular diseases via improved glycemic control. Encouraging patients with T2D and poor oral health conditions to receive periodontal treatment would improve health outcomes and still be cost saving or cost-effective.Keywords
Funding Information
- Harvard School of Dental Medicine
This publication has 38 references indexed in Scilit:
- Mortality in type 2 diabetes mellitus: magnitude of the evidence from a systematic review and meta-analysisBritish Journal of Diabetes, 2013
- Discovering medical conditions associated with periodontitis using linked electronic health recordsJournal of Clinical Periodontology, 2013
- Meta-Analysis of Cohort and Case–Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial FibrillationThe American Journal of Cardiology, 2011
- Diabetes mellitus and periodontitis: a tale of two common interrelated diseasesNature Reviews Endocrinology, 2011
- Mechanisms involved in the association between peridontal diseases and cardiovascular diseaseOral Diseases, 2011
- Diabetes mellitus and periodontal diseasePeriodontology 2000, 2007
- Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 DiabetesDiabetes Care, 2005
- Guidelines for Computer Modeling of Diabetes and Its ComplicationsDiabetes Care, 2004
- Untreated Periodontal Disease: A Follow‐Up on 30 CasesJournal of Periodontology, 2003
- The Greater Cincinnati/Northern Kentucky Stroke StudyStroke, 1998